- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Protein Kinase Inhibitors in United States
Total 3118 results
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPlasma Cell MyelomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); AmgenActive, not recruitingPlasma Cell MyelomaUnited States
-
Thomas Jefferson UniversityJanssen Scientific Affairs, LLCActive, not recruitingPlasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)WithdrawnPlasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States
-
Fox Chase Cancer CenterCompletedMultiple Myeloma | Advanced Solid TumorsUnited States
-
Dana-Farber Cancer InstituteNovartis; Millennium Pharmaceuticals, Inc.TerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Case Comprehensive Cancer CenterCompletedRefractory Multiple MyelomaUnited States
-
Ohio State University Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterCompleted
-
M.D. Anderson Cancer CenterAstraZenecaCompleted
-
Dana-Farber Cancer InstituteAmgenCompletedWaldenstrom's MacroglobulinemiaUnited States
-
Children's Hospital of Orange CountyCSL BehringCompleted
-
Dana-Farber Cancer InstituteBristol-Myers SquibbNo longer availableMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Attaya SuvannasankhaNational Cancer Institute (NCI)TerminatedRefractory Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical CenterCompleted
-
Cangene CorporationWithdrawnHemophilia BUnited Kingdom, United States
-
St. Jude Children's Research HospitalNot yet recruiting
-
Shayna Sarosiek, MDADC Therapeutics S.A.Recruiting
-
Masonic Cancer Center, University of MinnesotaCompletedLymphoma | Multiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityTerminatedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterDaiichi Sankyo UK Ltd.Terminated
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...MedImmune LLCCompleted
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Mayo ClinicrEVO BiologicsTerminatedThrombophilia Due to Acquired Antithrombin III DeficiencyUnited States
-
Emory UniversityMillennium Pharmaceuticals, Inc.Terminated
-
M.D. Anderson Cancer CenterAnorMEDCompleted
-
Washington University School of MedicinePaula C. & Rodger O. Riney Blood Cancer ResearchNot yet recruitingMultiple MyelomaUnited States
-
Yale UniversityGlaxoSmithKlineRecruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthAmgenSuspendedMultiple MyelomaUnited States
-
University of California, San FranciscoCompleted
-
Wake Forest University Health SciencesGlaxoSmithKline; AmgenActive, not recruitingMultiple MyelomaUnited States
-
University of ArkansasActive, not recruitingMultiple MyelomaUnited States
-
Washington University School of MedicineSanofiTerminatedMultiple MyelomaUnited States
-
University of Michigan Rogel Cancer CenterGlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
Duke UniversityCompleted
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
Yale UniversityCompleted
-
Spectrum Health HospitalsCompletedMultiple MyelomaUnited States
-
Washington University School of MedicineCompleted
-
University of ArkansasCompleted
-
Yale UniversityCelgene CorporationCompletedMultiple MyelomaUnited States